万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://journals.sagepub.com/home/chl
3、投稿网址：https://mc.manuscriptcentral.com/chl
4、官网邮箱：CHL.queries@sagepub.co.uk（编辑部）
5、出刊日期：月刊，一年出版十二期。
2021年4月3日星期六
投稿须知【官网信息】
Manuscript Submission Guidelines
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the journal’s submission site https://mc.manuscriptcentral.com/chl to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
SAGE Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.
Only manuscripts of sufficient quality that meet the aims and scope of Journal of Chemical Research will be reviewed. As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Journal of Chemical Research may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy.
If your paper is accepted, you must include a link on your preprint to the final version of your paper.
1. Open Access
Journal of Chemical Research is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.
For general information on open access at SAGE please visit the Open Access page or view our Open Access FAQs.
2. Article processing charge (APC)
From 1st January 2021, Journal of Chemical Research will become a fully open access journal. To facilitate this transition, all articles first submitted on or after 1st August 2020 will be subject to an open access article processing charge (APC) of 750 USD (plus tax where applicable), discounted from the full rate of 1,500 USD for a limited time, and will be published under a Creative Commons license. The APC will be payable on acceptance if the article is accepted after peer review.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.
3. What do we publish?
3.1 Aims & scope
Before submitting your manuscript to Journal of Chemical Research, please ensure you have read the Aims & Scope.
3.2 Article types
- Research articles
- Reviews
There is no limit on the number of references allowed.
3.3 Writing your paper
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
3.3.1 Experimental requirements
Authors must highlight any possible health and safety problems that could arise from compounds or procedures used in their work. Authors are warned that the use of domestic microwave ovens for chemical purposes can be unreliable and potentially hazardous. Where a domestic oven has been used a note to this effect should beadded to the general experimental section.
In the general experimental methods section, details should be given of any instruments and manufacturers that are used, and also the source of any spectroscopic or analytical services.
Convincing evidence of both purity and identity must be given for all new compounds; this will normally require good elemental analysis which should be quoted to 0.01%, the accuracy should normally be to within ±0.4%. The elemental composition may be defined by a high resolution mass spectrum with an error of not more than 10 ppm, but this must be accompanied by additional evidence of purity. Compounds that have been prepared before should be given the appropriate references. Relevant physical data, such as the melting point, should be quoted for comparison. 1H NMR shifts should be quoted to two decimal places. The multiplicity, relative integrals, and J values should be quoted to one decimal place and assignments given where possible. 13C chemical shifts should be quoted to one decimal place.
Other numerical data should not be quoted to a greater precision than the measurements warrant. Only IR peaks which characterise the functional groups of the compounds should be quoted. For low resolution mass spectra, up to eight major peaks, with the relative intensities, should be given. In general, a detailed discussion of the fragmentation pattern should not be included. Editors or referees may ask to see copies of spectra or of the appropriately authenticated original results of analyses. Authors who are unable to provide these may have their work rejected.
3.3.2 X-Ray crystallographic work
A brief mention of a crystallographic determination may be given in the title. Reference should be made to it in the abstract, without including cell dimensions and other crystal data.
The experimental details of data collection and structure analysis should be concise where routine procedures are used. Brief descriptions of any non-routine procedures should be given. The method used for structure solution and the treatment of H atoms where appropriate should be stated.
A conventional line drawing of the structure should normally be included, except in the simplest cases, and one perspective diagram (or stereo pair) if appropriate. Packing diagrams should not be included unless required to illustrate a specific chemical point. The atom numbering scheme should be shown in one of the diagrams. Each atom of the asymmetric unit should be assigned an Arabic numeral in parentheses following the chemical symbol: C(2), O(12), etc.
The description of the structure may be given in textual or tabular form; the latter is more appropriate if several structure determinations are being reported. Any special details, such as hydrogen bonding, should be mentioned. If significant comment is made on the structures, tables of selected bond parameters with estimated standard deviations can be included. Such a table should be restricted to significant dimensions only (e.g. it is rarely necessary to include data for phenyl rings). Differences from expected norms should be noted. The experimental section of the paper should include the following:
The crystal data, including the forumla, Mr.
The space group, cell dimensions and volume.
The number of formula units in the unit cell (Z).
The wavelength of the radiation and the linear absorption coefficient (u).
The diffractometer that was used and the range for collection data (a, h, k, l).
The total number of reflections that were collected, the number of independent reflections and the number that were used in the structure determination.
The programmes that were used, including appropriate citations.
The R factors and residual electron density, peak and hole.
Details of where the data have been deposited and the accesion number.
Journal of Chemical Research expects that the data will have been submitted to the CCDC or equivalent centre. A check list of items for deposition is available from the CCDC either by E-mail to fileserv@ccdc.cam.ac.uk with the one-line message sendme depform or through http://www.ccdc.cam.ac.uk/; the form can be saved as a simple text file. CCDC information should be listed in the ESI. The data that are deposited must include:
(1) A table of final fractional atomic coordinates.
(2) Any calculated coordinates (e.g. of hydrogen).
(3) A full list of bond lengths and angles with estimated standard deviations.
(4) A full list of displacement parameters in the form Bij or Uij (in Å2or pm²)
Tables of structure factors (F0, Fc) should not be sent, but retained by the authors so that they can be made available to the referees if requested. The CIF and a CheckCIF report must be submitted with the paper. Referees will require that a satisfactory response is given to any significant alerts that the report has raised.
The experimental details of the data collection and structure analysis for an X-ray structure should be tabulated and the CCDC number should be listed in the text as Electronic Supplementary Information (ESI) and not as a note in the references. A planar structure should also be given as well as the ORTEP structure.
Authors should present large table of data including crystallographic data, extensive theoretical calculations and biological results together with copies of spectra and electron microscopy pictures in the ESI. Editors may require the transfer of information from the text to the ESI. The content of the ESI should be briefly listed at the end of the experimental section.
3.3.3 Computation
Journal of Chemical Research will consider articles that contain computational results which support the experimental work described in the paper. The journal is not a vehicle for the publication of purely theoretical papers. In the results and discussion section of the text, the authors should give the name of the software that they have chosen to use. They should explain why its use was appropriate and any deviations that they have made from the default settings together with any specific constraints that they have applied to the particular calculations to achieve their objectives. The software used should be correctly referenced. Authors should show how the results of their calculations relate to the main experimental objectives of the paper.
In the experiemental section of the paper, the authors should provide the following details, which should be appropriately referenced. (a) the origin of the input file or visualisation tool; if the calculations from one piece of software have been used as the input for another, authors should show how this has been done; (b) the name and version of the software, level of theory and basis set used; (c) the nature and objectives of the calculations; (d) any deviations from the default settings of the software; (e) any specific constraints which have been applied to the particular calculations; and (f) the processes that were used to handle and present the results.
In addition, authors must retain the actual input and output files so that they can be made available to referees if requested. When the details of the calculations are given as Electronic Supplementary Information, the details of the methodology should be expanded.
3.3.4 Making your article discoverable
For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online
4. Editorial policies
4.1 Peer review policy
As standard practice, SAGE does not permit the use of author-suggested reviewers.
The journal’s policy is to have manuscripts reviewed by two expert reviewers. Journal of Chemical Research utilizes a single-blind peer review process in which the reviewer’s name and information is withheld from the author/double-blind peer review process in which the reviewer and authors’ names and information are withheld from the other. All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Reviewers make comments to the author and recommendations to Editor who then makes the final decision.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process.
Journal of Chemical Research is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for Journal of Chemical Research can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.
4.2 Authorship
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
Drafted the article or revised it critically for important intellectual content,
Approved the version to be published,
Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
4.3 Acknowledgements
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
4.3.1 Third party submissions
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
• Disclose this type of editorial assistance – including the individual’s name, company and level of input
• Identify any entities that paid for this assistance
• Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.
Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
4.3.2 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
4.4 Funding
Journal of Chemical Research requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
4.5 Declaration of conflicting interests
It is the policy of Journal of Chemical Research to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations.
4.6 Research ethics and patient consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
4.7 Clinical trials
Journal of Chemical Research conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
4.8 Reporting guidelines
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
4.9 Research Data
At SAGE we are committed to facilitating openness, transparency and reproducibility of research. Where relevant, Journal of Chemical Research encourages authors to share their research data in a suitable public repository subject to ethical considerations and to include a data accessibility statement in their manuscript file. Authors should also follow data citation principles. For more information please visit the SAGE Author Gateway, which includes information about SAGE’s partnership with the data repository Figshare.
5. Publishing policies
5.1 Publication ethics
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.
5.1.1 Plagiarism
Journal of Chemical Research and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
5.1.2 Prior publication
If material has been previously published, it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
5.2 Contributor’s publishing agreement
Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Journal of Chemical Research publishes manuscripts under Creative Commons licenses. The standard license for the journal is Creative Commons by Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit SAGE's OA licenses page.
Alternative license arrangements are available, for example, to meet particular funder mandates, made at the author’s request.
6. Preparing your manuscript
6.1 Formatting
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
6.2 Artwork, figures and other graphics
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines
Figures supplied in color will appear in color online.
6.3 Supplemental material
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplemental files.
6.4 Reference style
Journal of Chemical Research adheres to the SAGE Vancouver reference style. View the SAGE Vancouver guidelines to ensure your manuscript conforms to this reference style.
If you use EndNote to manage references, you can download the SAGE Vancouver EndNote output file.
6.5 English language editing services
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
7. Submitting your manuscript
7.1 How to submit your manuscript
Journal of Chemical Research is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/chl to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
7.2 Title, keywords and abstracts
Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.
7.3 Information required for completing your submission
Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
7.4 ORCID
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID IDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
If you do not already have an ORCID ID please follow this link to create one or visit our ORCID homepage to learn more.
7.5 Permissions
Please ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Journal Author Gateway.
8. On acceptance and publication
If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement. Once your manuscript files have been checked for SAGE Production, the corresponding author will be asked to pay the article processing charge (APC) via a payment link. Once the APC has been processed, your article will be prepared for publication and can appear online within an average of 30 days. Please note that no production work will occur on your paper until the APC has been received.
8.1 SAGE Production
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will made available to the corresponding author via our editing portal SAGE Edit, or by email to the corresponding author and should be returned promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorizing the change.
8.2 Online publication
One of the many benefits of publishing your research in an open access journal is the speed to publication. With no page count constraints, your article will be published online in a fully citable form with a DOI number as soon as it has completed the production process. At this time it will be completely free to view and download for all.
8.3 Promoting your article
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximize your article’s impact with Kudos.
9. Further information
Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Journal of Chemical Research editorial office as follows:
CHL.queries@sagepub.co.uk
10. Appealing the publication decision
Editors have very broad discretion in determining whether an article is an appropriate fit for their journal. Many manuscripts are declined with a very general statement of the rejection decision. These decisions are not eligible for formal appeal unless the author believes the decision to reject the manuscript was based on an error in the review of the article, in which case the author may appeal the decision by providing the Editor with a detailed written description of the error they believe occurred.
If an author believes the decision regarding their manuscript was affected by a publication ethics breach, the author may contact the publisher with a detailed written description of their concern, and information supporting the concern, at publication_ethics@sagepub.com
